Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 924 trials across Europe, recruiting first
Study of Pembrolizumab for Patients with Stage IIb/c Melanoma
DenmarkStudy on Using Iron Oxide to Visualize Tumor Spread in Glioblastoma Patients
The NetherlandsStudy on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
The NetherlandsStudy on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment
FranceStudy on the Safety and Effectiveness of SpectraCure P18 System and Verteporfin for Treating Localized Prostate Cancer in Men
GermanyStudy on Vinorelbine for Patients with Metastatic Colorectal Cancer
ItalyStudy of M9140 for Patients With Advanced Pancreatic Cancer
AustriaStudy of Pembrolizumab for Patients with High-Risk Stage IIB/IIC Melanoma
FranceStudy on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer
The NetherlandsStudy of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)
DenmarkStudy on Everolimus and Exemestane for Patients with Metastatic Breast Cancer
HungaryStudy of Anti-GD2-800CW for Imaging in Children with Neuroblastoma
The NetherlandsThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
